НовостиBenzingaGuggenheim Maintains Buy on Eloxx Pharma, Lowers Price Target to $40 Guggenheim Maintains Buy on Eloxx Pharma, Lowers Price Target to $40 Benzinga 2026.10.28 13:47 (GMT+0) Открыть на Benzinga Другие новости